Discussing the Role of MRD in CLL With Talal Hilal, MD
The HemOnc Pulse
Evolving Measurement of Minimal Residual Disease in Cancer Treatment
Exploring the advancements in measuring Minimal Residual Disease (MRD) in cancer care, the speakers discuss the significance of detecting even the smallest cancer cells to potentially achieve a cure. They highlight the improvements in diagnostic techniques and the ongoing quest for undetectable MRD as a potential indicator of successful treatment outcomes.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
